No retraction, correction or concern found when last checked on Oct 18, 2026.

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment

Yujing Huang, Xiaohan Guo, Yi Wu and 4 more

Signal Transduction and Targeted Therapy · 2024 · Review · CC BY

Abstract

Inflammation-associated diseases encompass a range of infectious diseases and non-infectious inflammatory diseases, which continuously pose one of the most serious threats to human health, attributed to factors such as the emergence of new pathogens, increasing drug resistance, changes in living environments and lifestyles, and the aging population. Despite rapid advancements in mechanistic research and drug development for these diseases, current treatments often have limited efficacy and notable side effects, necessitating the development of more effective and targeted anti-inflammatory therapies. In recent years, the rapid development of nanotechnology has provided crucial technological support for the prevention, treatment, and detection of inflammation-associated diseases. Various types of nanoparticles (NPs) play significant roles, serving as vaccine vehicles to enhance immunogenicity and as drug carriers to improve targeting and bioavailability. NPs can also directly combat pathogens and inflammation. In addition, nanotechnology has facilitated the development of biosensors for pathogen detection and imaging techniques for inflammatory diseases. This review categorizes and characterizes different types of NPs, summarizes their applications in the prevention, treatment, and detection of infectious and inflammatory diseases. It also discusses the challenges associated with clinical translation in this field and explores the latest developments and prospects. In conclusion, nanotechnology opens up new possibilities for the comprehensive management of infectious and inflammatory diseases.

References 804

1.
Inflammatory responses and inflammation-associated diseases in organs · 2017
No notice
2.
Leiba J, et al. Molecular actors of inflammation and their signaling pathways: mechanistic insights from zebrafish. Biology. 2023;12:153.
Not in our library10.3390/biology12020153
3.
Meizlish ML, Franklin RA, Zhou X, Medzhitov R. Tissue homeostasis and inflammation. Annu. Rev. Immunol. 2021;39:557-581.
Not in our library10.1146/annurev-immunol-061020-053734
4.
Sansbury BE, Spite M. Resolution of acute inflammation and the role of resolvins in immunity, thrombosis, and vascular biology. Circ. Res. 2016;119:113-130.
Not in our library10.1161/circresaha.116.307308
5.
Inflammation–Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing “the Epidemic” of Chronic Diseases · 2018
No notice
6.
Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428-435.
Not in our library10.1038/nature07201
7.
Neutrophils in chronic inflammatory diseases · 2022
No notice
8.
Brzezicka KA, et al. Suppression of autoimmune rheumatoid arthritis with hybrid nanoparticles that induce B and T cell tolerance to self-antigen. ACS Nano. 2022;16:20206-20221.
Not in our library10.1021/acsnano.2c05643
9.
Yoo D, et al. Anti‐inflammatory glycocalyx‐mimicking nanoparticles for colitis treatment: construction and in vivo evaluation. Angew. Chem. Int. Ed. 2023;62:e202304815.
Not in our library10.1002/anie.202304815
10.
Yuan J, et al. Targeted (otherapies). ACS Nano. 2021;15:16076-16094.
Not in our library10.1021/acsnano.1c04753
11.
Yasamineh S, et al. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. J. Nanobiotechnol. 2022;20:440.
Not in our library10.1186/s12951-022-01625-0
12.
Huang Y-S, et al. Metal nanoparticles and nanoparticle composites are effective against Haemophilus influenzae, Streptococcus pneumoniae, and multidrug-resistant bacteria. J. Microbiol. Immunol. Infect. 2022;55:708-715.
Not in our library10.1016/j.jmii.2022.05.003
13.
Kaur K, Kumar P, Kush P. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection. Biomed. Pharmacother. 2020;128:110297.
Not in our library10.1016/j.biopha.2020.110297
14.
Zhou Y, et al. Controlled copper in situ growth-amplified lateral flow sensors for sensitive, reliable, and field-deployable infectious disease diagnostics. Biosens. Bioelectron. 2021;171:112753.
Not in our library10.1016/j.bios.2020.112753
15.
González LF, et al. Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: a promising simple, effective, non-invasive, and low-cost therapy. J. Control Release. 2021;331:443-459.
Not in our library10.1016/j.jconrel.2020.11.019
16.
Zhang L, et al. Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment. Bioact. Mater. 2022;18:1-14.
Not in our library10.1016/j.bioactmat.2022.02.017
17.
Lussier F, Staufer O, Platzman I, Spatz JP. Can bottom-up synthetic biology generate advanced drug-delivery systems? Trends Biotechnol. 2021;39:445-459.
Not in our library10.1016/j.tibtech.2020.08.002
18.
Zeng Q, et al. Wound dressing: from nanomaterials to diagnostic dressings and healing evaluations. ACS Nano. 2022;16:1708-1733.
Not in our library10.1021/acsnano.1c08411
19.
Liu T, et al. Nanomaterials and nanomaterials-based drug delivery to promote cutaneous wound healing. Adv. Drug Deliv. Rev. 2023;193:114670.
Not in our library10.1016/j.addr.2022.114670
20.
Geng H, et al. Noble metal nanoparticle biosensors: from fundamental studies toward point-of-care diagnostics. Acc. Chem. Res. 2022;55:593-604.
Not in our library10.1021/acs.accounts.1c00598
21.
Parsamian P, et al. Enhanced nanobubble formation: gold nanoparticle conjugation to Qβ virus-like particles. ACS Nano. 2023;17:7797-7805.
Not in our library10.1021/acsnano.3c00638
22.
Avellan A, et al. Nanoparticle size and coating chemistry control foliar uptake pathways, translocation, and leaf-to-rhizosphere transport in wheat. ACS Nano. 2019;13:5291-5305.
Not in our library10.1021/acsnano.8b09781
23.
Darabdhara G, et al. Ag and Au nanoparticles/reduced graphene oxide composite materials: Synthesis and application in diagnostics and therapeutics. Adv. Colloid Interface Sci. 2019;271:101991.
Not in our library10.1016/j.cis.2019.101991
24.
Shabatina TI, Vernaya OI, Shimanovskiy NL, Melnikov MY. Metal and metal oxides nanoparticles and nanosystems in anticancer and antiviral theragnostic agents. Pharmaceutics. 2023;15:1181.
Not in our library10.3390/pharmaceutics15041181
25.
A comprehensive review on plasmonic-based biosensors used in viral diagnostics · 2021
No notice
26.
Leuschner F, et al. Silencing of CCR2 in myocarditis. Eur. Heart J. 2015;36:1478-1488.
Not in our library10.1093/eurheartj/ehu225
27.
Grippin AJ, et al. Dendritic cell-activating magnetic nanoparticles enable early prediction of antitumor response with magnetic resonance imaging. ACS Nano. 2019;13:13884-13898.
Not in our library10.1021/acsnano.9b05037
28.
Garrido C, et al. Gold nanoparticles to improve HIV drug delivery. Future Med Chem. 2015;7:1097-1107.
Not in our library10.4155/fmc.15.57
29.
Khan T, et al. Plant-based gold nanoparticles; a comprehensive review of the decade-long research on synthesis, mechanistic aspects and diverse applications. Adv. Colloid Interface Sci. 2019;272:102017.
Not in our library10.1016/j.cis.2019.102017
30.
Mechanisms of Silver Nanoparticle Release, Transformation and Toxicity: A Critical Review of Current Knowledge and Recommendations for Future Studies and Applications · 2013
No notice
31.
Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes · 2016
No notice
32.
Porter GC, et al. AgNP/Alginate Nanocomposite hydrogel for antimicrobial and antibiofilm applications. Carbohydr. Polym. 2021;251:117017.
Not in our library10.1016/j.carbpol.2020.117017
33.
Chakravarty M, Vora A. Nanotechnology-based antiviral therapeutics. Drug Deliv. Transl. Res. 2020;11:748-787.
Not in our library10.1007/s13346-020-00818-0
34.
Lara HH, Ixtepan-Turrent L, Garza-Treviño EN, Rodriguez-Padilla C. PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture. J. Nanobiotechnol. 2010;8:15.
Not in our library10.1186/1477-3155-8-15
35.
Yang Y, et al. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization. Biomaterials. 2021;264:120390.
Not in our library10.1016/j.biomaterials.2020.120390
36.
AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells. ACS Nano. 2008;3:279-290.
Not in our library10.1021/nn800596w
37.
Taheri S, et al. Substrate independent silver nanoparticle based antibacterial coatings. Biomaterials. 2014;35:4601-4609.
Not in our library10.1016/j.biomaterials.2014.02.033
38.
Ye S, et al. Antiviral activity of graphene oxide: how sharp edged structure and charge matter. ACS Appl. Mater. Interfaces. 2015;7:21571-21579.
Not in our library10.1021/acsami.5b06876
39.
Seyed Alian R, et al. Do nanoparticles cause hormesis? Early physiological compensatory response in house crickets to a dietary admixture of GO, Ag, and GOAg composite. Sci. Total Environ. 2021;788:147801.
Not in our library10.1016/j.scitotenv.2021.147801
40.
Xu P-Y, et al. Progress in antiviral fullerene research. Nanomaterials. 2022;12:2547.
Not in our library10.3390/nano12152547

All 804 references

Cited by papers we hold 2

Invasion and metastasis in cancer: molecular insights and therapeutic targets · 2025
No notice
Nanotechnology in healthcare, and its safety and environmental risks · 2024
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.